Cipla Medpro announces new distribution centre due to steady growth

Cipla Medpro announces new distribution centre due to steady growth

Cipla Medpro, the third largest pharmaceutical manufacturer in South Africa, today announced the construction of a new, purpose-built 16 000 M2 pharmaceutical storage facility in Rivergate Park, Parklands N2,  Cape Town.

This is according to Paul Miller, CEO of Cipla Medpro, who says that the company is expecting an aggressive growth phase in line with its ethos of advancing healthcare for all South Africans through its continuous support of the Department of Health (DoH).

“75 000 kilograms of product will be moved through the facility on a monthly basis, of which a major portion will form part of national tender supplies. This structure will serve as the main hub for all imports and distribution into Southern Africa and will enable us to provide a wider variety and greater quantity of the required medication to the DoH.”

He adds that the distribution centre will employ just under a hundred staff members and will achieve a level 2 Empowerdex BBBEE rating. “With a warehouse capacity of 22 000 pallets, this state-of-the-art storage facility is expertly designed to meet stringent climate control regulations.”

Miller explains that the pharmaceutical company decided to construct its facility in the Western Cape as Cipla Medpro is headquartered in Cape Town. “In addition, the Cape Town harbour has a proven track record of efficiency and we are confident that this decision will ensure optimal logistics.”

Miller says that local construction and design organisations will be contracted to complete the project and that the facility will be fully operational by November 2015. “We are confident that this distribution centre will be instrumental in providing a wider variety of medication to the South African market and will tie into our ethos of providing affordable healthcare to all.”


In the interest of our patients, in accordance with South African law and our commitment to expertise, MediHub cannot subscribe to the practice of online diagnosis. Please consult a medical professional for specific medical advice. If you have any major concerns, please see your doctor for an assessment. If you have any cause for concern, your GP will be able to direct you to the appropriate specialists.

Cipla Communications brings you the latest news from the Press, keeping you up to date with what's happening in the world of Cipla.
Visit the official COVID-19 government website to stay informed: